Combinations of bleeding and ischemic risk and their association with clinical outcomes in acute coronary syndrome.

Mamas, Mamas; Rashid, Muhammad

Abstract

Acute coronary syndromes (ACS) are an important cause of morbidity and mortality worldwide. Current guidelines recommend early management with potent antiplatelet agents and an early invasive coronary intervention strategy for both non-ST elevation myocardial infarction (NSTEMI) and ST-elevation myocardial infarction (STEMI). The mainstay of pharmacologic treatment for ACS is the use of potent antithrombotic therapy to minimize the risk for further ischemic events, which comes at an expense of an increased risk of bleeding complications that are associated with high rates of morbidity and mortality.

Citation

Mamas, M., & Rashid, M. (2019). Combinations of bleeding and ischemic risk and their association with clinical outcomes in acute coronary syndrome. International Journal of Cardiology, 7-14. https://doi.org/10.1016/j.ijcard.2019.05.035

• Acceptance Date: May 15, 2019
• Publication Date: Sep 1, 2019
• Journal: International Journal of Cardiology
• Print ISSN: 0167-5273
• Publisher: Elsevier
• Pages: 7-14
• DOI: https://doi.org/10.1016/j.ijcard.2019.05.035
• Keywords: Grce, Crusade, risk scores, outcomes, treatment
• Public URL: https://keele-repository.worktribe.com/output/413590
• Publisher URL: https://doi.org/10.1016/j.ijcard.2019.05.035